Print

Findings from a preliminary study published in the March 21 JBJS suggest that vancomycin powder may be effective for reducing risk of surgical site infection (SSI) following surgery for early-onset scoliosis, even when previous surgeries have been performed without it. 

Members of the research team performed a retrospective study of 36 patients who underwent 191 procedures for early-onset scoliosis. During the study period, they found that 14 of patients (39 percent) developed one or more deep SSI, and two patients had multiple acute infections. The researchers noted 87 procedures with 12 infections in the control cohort (13.8 percent SSI rate per procedure) and 104 procedures with five infections in the vancomycin cohort (4.8 percent SSI rate per procedure). Learn more...